Clindamycin 900 mg IV q8h - S
This guideline is intended to help guide antimicrobial therapy for adult patients (defined as patients admitted to adult service lines) following the results of Gram Stain, Organism
g
Summary: Combination antibiotic therapy for invasive infections with Gram-negative bacteria is employed in many health care facilities, especially for certain subgroups of
Gram-negative bacteria (GNB) are among the world's most significant public health problems due to their high resistance to antibiotics
Gram-negative bacteria cause infections including pneumonia, bloodstream infections, wound or surgical site infections, and meningitis in healthcare settings
Gram-positive cocci and Gram-negative rods are common findings from a Gram stain of a wound specimen
[1] It was later classified as
Gram-negative rods
Pseudomonas
time trends in the incidence rates of GNR bacteremia and FQ-resistant GNR bacteremia in HCT recipients during an era of levofloxacin prophylaxis
Shorter courses of antibiotic therapy (eg, 7 days) have been shown to have similar clinical response and
Gram-negative bacilli Although it is not approved for use in children, levofloxacin (Levaquin) is effective in children who have persistent or recurrent acute otitis media
, Stenotrophomonas associated with true infection and should generally be treated with an appropriate agent
0; D
4% in Korean patients with DFIs, and it is better to reduce the likelihood of resistance and reserve it as a useful definite oral antimicrobial agent
A recent analysis from PDOPPS reported that, for treatment of gram-negative peritonitis, empirical aminoglycoside was associated with a higher likelihood of medical cure than ceftazidime
For additional information, refer to the Partners penicillin / E
Bacterial bloodborne infections are a common cause of morbidity and mortality among allogeneic hematopoietic cell transplant (HCT) patients, occurring in up to 55% of this population
There are many different reactions to what are similar antibiotics
aeruginosa skin, soft tissue, and bone infections will be reviewed here
Levofloxacin is the L-form of the fluoroquinolone antibacterial agent, ofloxacin